Executive summary - Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines

摘要

The objective of this guideline1 is to provide recommendations for monitoring the use of immunosup-pressive drugs so that clinically significant side effects can be either avoided or recognized in a timely fashion. This guideline does not provide recommendations concerning indications for use of these drugs. Rather, it should be used exclusively to achieve maximal patient safety when these nonsteroidal immunosuppressive medications are prescribed. Sufficient information related solely to treating pulmonary diseases was available for some of the drugs covered by this guideline; however, recommendations were partially or entirely abstracted from nonpulmonary studies for a number of these agents because of a lack of information in the published literature about their use for pulmonary disorders or for lung transplant recipients. Because of its focus on common and unique side effects associated with specific drugs, this guideline can provide important information to both physicians and patients.